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Abstract: Humans are exposed to nanoparticles (NPs; diameter < 100 nm) from ambient 
air and certain workplaces. There are two main  types of NPs; combustion-derived NPs 
(e.g.,  particulate  matters,  diesel  exhaust  particles,  welding  fumes)  and  manufactured or 
engineered NPs (e.g., titanium dioxide, carbon black, carbon nanotubes, silver, zinc oxide, 
copper oxide). Recently, there have been increasing reports indicating that inhaled NPs  
can  reach  the  brain  and  may  be  associated  with  neurodegeneration.  It  is  necessary  to 
evaluate the potential toxic effects of NPs on brain because most of the neurobehavioral 
disorders  may  be  of  environmental  origin.  This  review  highlights  studies  on  both 
combustion-derived NP- and manufactured or engineered NP-induced neuroinflammation, 
oxidative stress, and gene expression, as well as the possible mechanism of these effects in 
animal models and in humans. 
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1. Introduction  
In  this  review  the  term  “nanoparticles”  (NPs)  is  used  to  define  particle  less  than  100  nm  in 
diameter.  NPs  are  generally  classified  as  combustion-derived  NPs  (e.g.,  particulate  matters  (PM), 
diesel exhaust particles, welding fumes) and manufactured or engineered NPs (e.g., titanium dioxide, 
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carbon black, carbon nanotubes, silver, zinc oxide, copper oxide). Although these two types of NPs 
might be the same size, there are obvious differences between them.  Combustion-derived NPs are 
polydispersed, chemically complex nature, soluble or poorly soluble form and toxicity may be due to 
physicochemical characteristics on their surface [1]. In contrast, manufactured or engineered NPs are 
monodispersed,  precise  chemical  nature,  solid  mainly  spherical  and  may  be  tube,  fiber  or  wire  
form [1]. Regarding combustion-derived NPs, several epidemiological studies have demonstrated that 
exposure to elevated levels of PM in urban air is associated with adverse health effects in humans, 
including an increase in morbidity and mortality related to pulmonary and cardiovascular diseases in 
susceptible populations [2–5]. Recently, the toxicity of diesel engine-derived NPs  has come to be 
recognized as an emerging social problem. Currently, many manufactured or engineered commercial 
NPs  have  been  used  in  electronics,  cosmetics,  medicines,  fabrics,  and  computer  displays  [1,6–8]. 
However, research on the potential health risks of exposure to NPs lags behind the rapid development 
of nanotechnology. Intratracheal instillation of commercial carbon black (CB) NPs causes pulmonary 
inflammation and these NPs are translocated to mediastinal lymph nodes and have been shown to  
size-specifically upregulate expression of chemokine mRNAs in the lungs and lymph nodes [9]. A rat 
study has shown that 
13C NPs may be taken up directly into the brain (the olfactory bulb) from the 
olfactory epithelium via the olfactory nerves [10], and other studies have shown that the nanosized 
component of PM can reach the brain and may be associated with neurodegenerative diseases [11,12]. 
Some NPs are difficult to eliminate by physiological clearance systems and may accumulate within the 
brain over long periods and trigger toxic effects [13]. 
NPs of various chemicals have been found to be more toxic and inflammogenic than micro-sized 
particles of the same chemicals when delivered at an equal mass dose [14,15]. Although in vivo and  
in  vitro  studies  have  shown  that  combustion-derived  NPs  are  neurotoxic,  it  has  been  difficult  to 
evaluate hazard assessment of manufactured NPs, because these NPs readily become aggregations [16]. 
In  this  review,  we  highlight  research  on  both  of  combustion-derived  NP-  and  manufactured  or 
engineered  NP-induced  neuroinflammation  and  neurotoxicity  and  the  possible  mechanisms  of  the 
effect of NPs in animal models and in human. 
2. Nanoparticles and Translocation to the Brain 
Recently, there has been increasing incidence of neurodegenerative diseases such as Alzheimer’s 
disease [17], Parkinson’s disease, Huntington’s disease [18], and primary brain tumors [19]. The exact 
etiology  of  these  diseases  is  unknown,  but  environmental  pollutants,  including  NPs,  may  be  an 
important  risk  factor.  NPs  may  enter  the  human  body  by  various  routes—including  inhalation, 
injection,  dermal  penetration,  and  ingestion—and  may  then  be  distributed  by  means  of  systemic 
circulation to various tissues [20,21], perhaps including the brain. 
There has been some argument about whether or not NPs can cross the blood–brain barrier (BBB), 
which separates blood from cerebrospinal fluid and is made of endothelial cells connected by tight 
junctions that limit the entry of many substances into the brain [22]. However, direct disruption of 
neuronal  cell  membranes  by  NPs  would  allow  their  entry  into  the  brain  [23,24].  For  example, 
intravenous,  intraperitoneal,  or  intracerebral  administration  of  Ag,  Cu,  or  Al  NPs  (50–60  nm) 
reportedly disrupts the BBB, as indicated by staining with albumin-bound Evans blue [23]. Int. J. Mol. Sci. 2011, 12                       
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Several studies have suggested that the olfactory nerve pathway should be considered as a portal of 
entry to the central nervous system in humans who are environmentally or occupationally exposed to 
airborne  NPs  [10,25,26].  In  a  landmark  study  in  1970,  De  Lorenzo  used  ultrafine  particle  to 
demonstrate that, in squirrel monkeys, intranasally instilled Ag-coated colloidal Au particles (50 nm) 
translocate anterogradely in the axons of the olfactory nerves to the olfactory bulbs [25]. It has been 
also shown that Mn, Cd, Ni, and Co nanomaterials that come into contact with the olfactory epithelium 
can  be  transported  to  the  brain  via  the  olfactory  neurons  [27–31].  Oberdörster  and  colleagues 
demonstrated that inhalation of ultrafine elemental 
13C particles (36 nm) by rats for 6 h in a whole-body 
exposure chamber leads to a significant and persistent increase in the accumulation of 
13C NPs in the 
olfactory bulb on day 1 and that the NP concentration continues to increase up to day 7 [10]. The same 
study also showed that concentrations of 
13C NPs are significantly  increased  in the cerebrum and 
cerebellum but that the increase is inconsistent; that is, it is significant only on one additional day of 
the post-exposure period (day 1). 
In  another  study,  30-nm  manganese  oxide  NPs  were  found  in  different  parts of  rat  brain  after 
intranasal  instillation,  and the  investigators suggested that the NPs had  moved to the brain  by the 
olfactory neuronal pathway [31]. It has also been shown that mRNAs of proinflammatory cytokines 
and chemokines are induced in the olfactory bulb, but not in the hippocampus, of mice intranasally 
instilled  with  14-nm  CB  particles  [32];  these  particles  might translocate to the  olfactory  bulb  via 
olfactory neurons and activate major immune cell microglia, which in turn up-regulates the expression 
of proinflammatory cytokine and chemokine mRNAs. Taken together, it is suggested that the NPs 
might be involved in inflammation in the brain.  
3. Nanoparticles and Oxidative Stress 
Combustion-derived NPs: PM that includes NPs can trigger free radical activity on the surface of 
the particles [33–35]. Free radicals or oxidative stress may damage lipids, nucleic acids, and proteins at 
the site of particle deposition and at translocation sites, and the brain  is particularly  vulnerable to 
oxidative stress because of its high energy demand, low level of antioxidants, and high cellular content 
of lipids and proteins [36]. Block and colleagues reported that NPs from diesel engine exhaust can 
damage dopaminergic neurons in primary central nervous system cultures via significantly high levels 
of  free  radicals  produced  by  microglial  activation  [11].  ROS  and  oxidative  stress  have  been 
experimentally  implicated  in  the  pathogenesis  of  neurodegenerative  disorders.  Further  studies  of 
oxidative  stress  associated  with  selective  gene  expression  analyses  and  immunological  biomarkers 
would improve our understanding of the mechanisms of neuroinflammation and neurodegeneration 
associated with NPs. 
Manufactured or engineered NPs: Oxidative stress induced by functionality on the surface of NPs 
plays a critical role in the common mechanism of their toxicity [10,37] and triggers inflammation in 
the  organs  in  which  NPs  are  deposited.  [38].  NPs  such  as  C60  fullerenes,  single-walled  carbon 
nanotubes, quantum dots, and ultrafine particles produce reactive oxygen species (ROS) especially 
when exposed to light (particularly UV light) or transition metals [39–48]. For example, Ag-25 NPs 
generate ROS and induce oxidative DNA damage in the brain. [49]. Exposure of mice deficient in 
apolipoprotein E to concentrated ambient NPs results in enhanced levels of oxidative stress in the  Int. J. Mol. Sci. 2011, 12                       
 
 
6270
brain  [36].  ROS  are  reportedly  associated  with  neurodegenerative  disorders  such  as  Parkinson’s 
disease, Alzheimer’s disease, and Huntington’s disease [18]. Moreover, a recent study indicated that 
maternal  exposure  to  titanium  oxide  (TiO2)  NPs  alters  the  expression  level  of  genes  related  to 
apoptosis and oxidative stress in newborn mouse pups [50]. 
4. Nanoparticles and in Vivo Animal Studies 
Combustion-derived  NPs:  In  2005,  it  was  first  reported that the  levels  of  the  proinflammatory 
cytokines interleukin (IL)-1 and tumor necrosis factor (TNF)- and the transcription factor NF-B 
are higher in brain tissues of mice exposed to PM than in brain tissues of control animals [51]. These 
findings suggest that components of PM may trigger an inflammatory response in nervous tissue and 
that they may contribute to the pathophysiology of neurodegenerative diseases.  
The results of a study conducted at the National Institute for Environmental Studies, Japan, indicated 
that 1-month exposure to NP-rich diesel exhaust (NRDE; generated from an Hino diesel engine (J08C; 
Hino Motors Ltd., Hino, Japan)) and/or weekly  injection of LTA  may separately  induce neurotoxic 
effects by modulating extracellular glutamate levels and expression of N-methyl-D-aspartate (NMDA) 
receptor  subunits  and  related  kinases  and  transcription  factors  in  the  mouse  olfactory  bulb  [52]. 
Insoluble  or  poorly  soluble  NPs  can  enter  the  brain  by  nasal  route  via  neuronal  transsynaptic  
transport [10,31], and uptake through the BBB from systemic circulation [23,53]. NPs from diesel 
exhaust might be translocated to the olfactory bulb, where they stimulate neurotransmitter release from 
neurons such as periglomerular cells, tuft cells, mitral cells, and granule cells into the extracellular 
fluid. Increased extracellular glutamate levels may be due to enhanced synthesis, reduced reuptake, or 
blockade  of  various  types  of  glutamate  receptors  on  the  postsynaptic  membrane.  Impairment  of 
glutamate uptake by the glutamate transporter is a possible candidate in the NRDE-induced increase in 
extracellular  glutamate  levels,  which  in  turn  enhances  expression  of  the  NMDA  receptor  subunit 
mRNA in the olfactory bulb [52]. 
In another study, expression in mouse hippocampus of genes related to spatial learning ability and 
memory function was examined after exposure of the animals to NRDE for 1 month with or without a 
bacterial cell wall component [54]. The relative mRNA levels of the NMDA receptor subunits and 
proinflammatory cytokines were higher in the hippocampus in the NRDE/LTA (+) group, and poor 
learning performance was observed. However, NRDE exposure alone did not affect gene expressions 
and learning performance. Excitatory amino acids, especially glutamate, may induce neuronal damage 
mediated by abnormal activation of specific NMDA receptor subunits in the hippocampus, leading to 
impairment of spatial learning, and upregulation of NMDA receptor subunit expression may be due to 
a compensatory response to reduction in the number of functional receptors.  
In a recent study under physiologically relevant conditions, female BALB/c mice were exposed to 
clean  air,  a  moderate  dose  (35  µg/m
3)  of  NRDE  (M-NRDE),  a  high  dose  (122  µg/m
3) of  NRDE  
(H-NRDE), or filtered diesel exhaust (F-DE) for 3 months in the absence of LTA [55]. Mice exposed 
to  H-NRDE  took  longer  to  reach  a  hidden  platform  and  showed  higher  levels  of  expression  of  
the  mRNAs  of  the  NMDA  receptor  subunit  NR2A,  the  proinflammatory  cytokine  CCL3,  and  
brain-derived neurotrophic factor (BDNF) in the hippocampus relative to expression in the control 
group. Interestingly, the level of BDNF mRNA expression, but not that of NGF mRNA expression, Int. J. Mol. Sci. 2011, 12                       
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was upregulated in the groups exposed to H-NRDE and F-DE, however, no significant difference in 
BDNF mRNA was observed between the these two groups. The fact that the concentration of gases 
such as CO, SO2, NOx, NO2, NO, and CO2 in the H-NRDE and F-DE chambers were approximately 
the same indicates that the effect may have been due to the gaseous constituents of the diesel exhaust 
rather than to NPs [55]. The H-NRDE dose was slightly higher than the environmental quality standard 
for suspended particulate matter in Japan (100 µg/m
3). These findings show that subchronic, high-dose 
NRDE exposure affects expression of genes related to hippocampal-dependent spatial learning and 
memory  function  in  female  mice.  However,  whether  the  H-NRDE  concentration  used  presents  a 
danger to human cognitive function is not known. 
Developmental  nanotoxicological  studies  have  shown  that  gestational  or  neonatal  inhalation 
exposure to diesel exhaust during a critical period of brain development affects sexual differentiation 
by modulating the expression of estrogen receptors  and  in the mouse cerebrum [56]. Furthermore, 
intrauterine exposure to low levels of diesel exhaust reduces spontaneous locomotor activity and alters 
the levels of monoamine neurotransmitters such as dopamine and noradrenaline and their metabolites 
in different brain regions of 4- to 5-week-old mice [57].  
Manufactured  or  engineered  NPs:  The  mRNAs  of  IL-1  and  TNF-,  chemokines  (monocyte 
chemoattractant  protein-1/CCL2  and  macrophage  inflammatory  protein-1/CCL3),  and  
momokine-induced interferon-gamma/CXC chemokine ligand (CXCL9) are induced in the olfactory 
bulb, but not in the hippocampus, of mice intranasally instilled with 14-nm CB [32]. Alteration of 
neurotransmitter levels and proinflammatory cytokines  in the mouse olfactory bulb after  intranasal 
instillation  of  14-nm  CB  NPs  with  or  without the  bacterial  cell  wall  component  lipoteichoic  acid 
(LTA)  derived  from  Staphylococcus  aureus  was  also  reported  [58].  Extracellular  glutamate  and 
glycine levels and IL-1 mRNAs were upregulated in the olfactory bulbs of CB-instilled mice, and 
LTA enhanced these effects [58]. Moreover, low levels of ultrafine PM exposure elicited inflammatory 
responses mediated by MAP kinase pathways, and high levels of exposure lead to cell death [59]. A 
recent in vivo study in ICR mice showed that aluminium oxide (alumina) NPs induced apoptosis via 
increased caspase-3  gene, and  impaired spatial  learning behavior and suggested that mitochondrial 
impairment  plays  a  key  role  in  neurotoxicity  of  nano-alumina  [60].  It  was  demonstrated  that  
nano-sized TiO2 (20–100 nm) was detected in cerebral cortex, hippocampus and olfactory bulb of  
6-week-old  male  mice  by using  field emission-type scanning electron microscopy (FE-SEM) after 
prenatal exposure [61]. Regardless of dosage and route of administration, once NPs enter the blood 
stream of a pregnant mother mouse, they could move to the offspring brain through under-developed 
blood-brain-barrier [62,63]. 
In  vivo  experiments  are  necessary  to  assess  sensitivity  of  organ  system  to  NPs,  as  well  as 
pharmacokinetic factors, the time course of brain development, and cell-to-cell interactions that cannot 
be modeled in vitro.  
5. Nanoparticles and in Vitro Studies 
Combustion-derived NPs: In vitro study has shown that microglia are activated by DEP to produce 
extracellular superoxide through NADPH oxidase, which is selectively toxic to dopmine neurons [11]. 
It  has  been  also  shown  that  DEP  impair  the  blood–brain  barrier  and  cause  capillaries  to  release  Int. J. Mol. Sci. 2011, 12                       
 
 
6272
TNFα in vitro,  contributing to inflammation [64].  Moreover, co-exposure of DEP (5 μg/mL) with 
lipopolysaccharide (2.5 ng/mL) in primary neuron–glia cultures synergistically increased nitric oxide 
production, TNF-α release, and dopamine neurotoxicity [65]. 
Manufactured or engineered NPs: Several in vitro studies have indicated the potential toxicity of 
NPs to various types of neuronal and glial cells. PC12 neuronal cell lines are commonly used for 
neurobiological  and  neurochemical  assessment  of  NP-induced  neurotoxicity.  Exposure  of  PC12  
cells  to  40-nm  manganese  oxide  NPs  dose-dependently  depleted  dopamine  and  its  metabolites, 
dihydroxyphenylacetic acid and homovanillic acid and those depletion were associated with significantly 
increased  production of  ROS [66].  Furthermore, exposure to 0.15- to 15-nm  anionic  magnetic  NPs 
triggered dose-dependent diminished viability of PC12 cells using methyl-thiazol-tetrazolium (MTT) 
method [67]. In addition,  Wang and colleagues (2009) showed that dopamine system-related gene 
expression is altered in PC12 cells exposed to Mn (40 nm), Ag (15 nm), or Cu (90 nm) NPs [68]. 
These investigators found that the Cu NPs induce dopamine depletion in PC12 cells and that the Mn 
NPs  induce  a  similar  effect;  Wang  and  colleagues  suggested  that  the  dopaminergic  neurotoxicity 
induced by the Mn and Cu NPs may share some mechanisms associated with neurodegeneration. A 
recent  in  vitro  study  using  a  dopaminergic  PC12  cell  line  indicated that  SiO2-NPs  decreased  cell 
viability,  triggered  oxidative  stress,  disturbed  cell  cycle,  induced  apoptosis  and  the  p53  mediated 
signaling pathway [69]. 
BV2 is an immortalized mouse microglial cell line commonly used to assess cellular toxicity for 
pharmacological agents, PM, and environmental chemicals [11,70]. Exposure of BV2 cells to Degussa 
P25, a commercially available TiO2 nanomaterial, results in immediate and prolonged release of ROS 
and upregulation of inflammatory, apoptotic, and cell cycling pathways, as well as downregulation of 
energy  metabolism  [71].  Apart  from  PC12  and  BV2  cell  lines  in  nanotoxicology,  a  recent  study 
indicated that exposure to ZnO NPs in mouse neural stem cells induced cell apoptosis [72].  
In vitro studies have some limitations; for example, they do not permit assessment of developmental 
and  functional  events  in  a  single  individual.  Nevertheless,  in  vitro  nanotoxicological  studies  are 
necessary  for  clarification  of  the  mechanism  of  action  of  NPs  without  the  influence  of  nutrition, 
endocrine status, and other variables. Therefore, a combination of both in vivo and in vitro studies 
would improve our ability to assess the risks of various NPs. 
6. Nanoparticles and Human Studies 
Combustion-derived  NPs:  Human  data  on  the  potential  health  hazards  of  NP  exposure  under  
real-world conditions is limited. Human studies carried out in Mexico City indicate that exposure to 
severe  air  pollution  including  PM  is  associated  with  brain  inflammation  via  increased  production  
of  cyclooxygenase-2  (an  inflammation  mediator)  and  accumulation  of  a  42-amino-acid  form  of 
-amyloid (an Alzheimer’s disease marker) [73]. 
Some  reports  indicating  a  statistically  significant  association  between  ambient  ultrafine  
particle  concentrations  and  increased  risk  of  cardiopulmonary  morbidity  and  mortality  has  been 
published [74,75]; however, interpretation of this association remains problematic [76]. One major 
problem is that separating NPs from other toxicologically relevant PM2.5 and PM10 fractions and 
gaseous components (nitrogen oxides, carbon monoxide, ozone) of the complex air mixture is difficult, Int. J. Mol. Sci. 2011, 12                       
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and exposure measurement errors are introduced by the use of central site monitoring data in place of 
personal exposure data [74]. 
Diesel exhaust particles are a major constituent of ambient PM, and most particles emitted directly 
from diesel exhaust are smaller than 1 m in diameter [77,78]. In a clinical study on the effects of 
diesel exhaust on humans, healthy young male volunteers were exposed for 1 h to whole diesel exhaust 
from a Volvo Diesel engine (Volvo TD45, 4.5 L, 4 cylinders, 680 rpm) during exposure and for 1 h after 
exposure, brain electrical activity was monitored by means of quantitative electroencephalography [79]. 
A significant increase in median power frequency in the frontal cortex within 30 min exposure was 
observed in these volunteers. These changes in brain activity may have been associated with NPs that 
either  penetrated  the  brain  or  affected  neurophysiologic  signaling  [79].  Toxicologically  relevant 
physicochemical  properties  of  NPs  from  diesel  exhaust  may  differ  from  the  properties  of  other  
NPs [76], and it is suggested that different NPs have a specific neurotoxic and neurobehavioral effects.  
Manufactured  or  engineered  NPs:  A  few  clinical  studies  have  shown  that  laboratory-generated 
NPs, such as elemental carbon and zinc oxide NPs, adversely affect pulmonary health [80,81]. The 
first evidence of NP-related disease in humans was found in seven Chinese workers in a print factory 
where a polyacrylic ester paste containing NPs was used; the workers suffered from an unusual and 
progressive lung disease; two of the workers died of the disease [82].  
Further studies are necessary to assess the human health risks of ambient and engineered NPs and to 
aid in the establishment of regulations regarding exposure to NPs. 
7. Conclusions 
On the basis of our findings and those of other investigators, we have summarized various pathways 
for  NP-induced  neurotoxicity  in  Figure  1.  Although  numerous  in  vivo  and  in  vitro  studies  have 
provided evidence of the toxic effects of various types of NPs, our understanding of the potential 
health and safety issues regarding NPs lags behind the rapid commercialization of nanomaterials. The 
benefits of nanomaterials must be weighed against their potential toxic effects. One major problem is 
lacking  information  on  the  possible  adverse  health  effects  caused  by  exposure  to  different 
nanomaterials [83]. Therefore, understanding of the neurotoxic effects of manufactured or engineered 
NPs would help in the development of safety guidelines by authorities to promote nanotechnology for 
applications without hazard. 
Figure  1.  Potential  pathways  of  nanoparticle-induced  neurotoxicity.  NPs  deposited  in  the  nasal 
mouse may enter the brain via olfactory bulb. Another portal of entry of NPs to brain is from systemic 
circulation. In the brain, NPs may induce inflammation, apoptosis and oxidative stress by releasing 
various mediators from microglia and astrocyte. Depends on production of toxic (e.g., NO, excitatory 
neurotranmsitters) or anti-toxic mediators (e.g., anti-inflammatory cytokines, neurotrophins), it may 
lead to neurodegeneration or neuroregeneration. Int. J. Mol. Sci. 2011, 12                       
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Figure 1. Potential pathways of nanoparticles-induced neurotoxicity.  
 
Acknowledgments 
This research was supported in part by the Environmental Research and Technology Development 
Fund (C-0901) of the Ministry of the Environment, Japan. 
Conflicts of Interest 
The authors declare that they have no competing financial interests. 
References 
1.  Oberdörster,  G.;  Oberdörster,  E.;  Oberdörster,  J.  Nanotoxicology:  An  emerging  discipline 
evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113, 823−839. 
2.  Dockery, D.W.; Pope, C.A., III.; Xu, X.; Spengler, J.D.; Ware, J.H.; Fay, M.E.; Ferris, B.G., Jr.; 
Speizer, F.E. An association between air pollution and mortality in six US cities. N. Engl. J. Med. 
1993, 329, 1753–1759. 
3.  Pope, C.A.; III.; Burnett, R.T.; Thun, M.J.; Calle, E.E.; Krewski, D.; Ito, K.; Thurston, G.D. Lung 
cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 
2002, 287, 1132−1141. Int. J. Mol. Sci. 2011, 12                       
 
 
6275
4.  Peters, A.; Döring, A.; Wichmann, H.E.; Koenig, W. Increased plasma viscosity during an air 
pollution episode: A link to mortality? Lancet 1997, 349, 1582–1587. 
5.  Penttinen,  P.;  Timonen,  K.L.;  Tittanen,  P.;  Mirme,  A.;  Ruuskanen,  J.;  Pekkanen,  J.  Ultrafine 
particles in urban air and respiratory health among adult asthmatics. Euro. Respir. J. 2001, 17, 
428–435. 
6.  Donaldson, K. Resolving the nanoparticles paradox. Nanomedicine 2006, 1, 229–234. 
7.  Medina, C.; Santos-Martinez, M.J.; Radomski, A.; Corrigan, O.I.; Radomski, M.W. Nanoparticles: 
Pharmacological and toxicological significance. Br. J. Pharmacol. 2007, 150, 552–558. 
8.  Linkov,  I.;  Satterstrom,  F.K.;  Corey,  L.M.  Nanotoxicology  and  nanomedicine:  Making  hard 
decisions. Nanomedicine 2008, 4, 167–171. 
9.  Win-Shwe,  T.T.;  Yamamoto,  S.;  Kakeyama,  M.;  Kobayashi,  T.;  Fujimaki,  H.  Effect  of 
intratracheal instillation of ultrafine carbon black on proinflammatory cytokine and chemokine 
release and mRNA expression in lung and lymph nodes of mice. Toxicol. Appl. Pharmacol. 2005, 
209, 51−61. 
10.  Oberdörster, G.; Sharp, Z.; Atudorei, V.; Elder, A.; Gelein, R.; Kreyling, W.; Cox, C. Translocation 
of inhaled ultrafine particles to the brain. Inhal. Toxicol. 2004, 16, 437–445. 
11.  Block,  M.L.;  Wu,  X.;  Pei,  Z.;  Li,  G.;  Wang,  T.;  Qin,  L.;  Wilson,  B.;  Yang,  J.;  Hong,  J.S.; 
Veronesi,  B.  Nanometer  size  diesel  exhaust  particles  are  selectively  toxic  to  dopaminergic 
neurons:  The  role  of  microglia,  phagocytosis,  and  NADPH  oxidase.  FASEB  J.  2004,  18,  
1618–1620. 
12.  Peters, A.; Veronesi, B.; Calderon-Garciduenas, L.; Gehr, P.; Chen, L.C.; Geiser, M.; Reed, W.; 
Rothen-Rutishauser, B.; Schurch, S.; Schulz, H. Translocation and potential neurological effects 
of fine and ultrafine particles, A critical update. Part. Fibre Toxicol. 2006, 3, 1–13. 
13.  Hu, Y.L.; Gao, J.Q. Potential neurotoxicity of nanoparticles. Int. J. Pharm. 2010, 394, 115−121. 
14.  Donaldson,  K.;  Stone,  V.;  Clouter,  A.;  Renwick,  L.;  MacNee,  W.  Ultrafine  particles.  Occup. 
Environ. Med. 2001, 58, 211–216. 
15.  Donaldson,  K.;  Stone,  V.;  Seaton,  A.;  MacNee,  W.  Ambient  particle  inhalation  and  the 
cardiovascular system: Potential mechanisms. Environ. Health Perspect. 2001, 109, 523–527. 
16.  Morimoto,  Y.;  Kobayashi,  N.;  Shinohara,  N.;  Myojo,  T.;  Tanaka,  I.;  Nakanishi,  J.  Hazard 
assessments of manufactured nanomaterials. J. Occup. Health 2010, 52, 325–334. 
17.  Farrer, L.A. Intercontinental epidemiology of Alzheimer disease: A global approach to bad gene 
hunting. JAMA 2001, 285, 796–798. 
18.  Matés, J.M.; Pérez-Gómez, C.; Núñez de Castro, I. Antioxidant enzymes and human diseases. 
Clin. Biochem. 1999, 32, 595–603. 
19.  Orringer, D.A.; Koo, Y.E.; Chen, T.; Kopelman, R.; Sagher, O.; Philbert, M.A. Small solutions 
for big problems: The application of nanoparticles to brain tumor diagnosis and therapy. Clin. 
Pharmacol. Ther. 2009, 85, 531–534. 
20.  Burch, W.M. Passage of inhaled particles into the blood circulation in humans. Circulation 2002, 
106, e141–e142. 
21.  Takenaka,  S.;  Karg,  E.;  Roth,  C.;  Schulz,  H.;  Ziesenis,  A.;  Heinzmann,  U.;  Schramel,  P.;  
Heyder,  J.  Pulmonary  and  systemic  distribution  of  inhaled  ultrafine  silver  particles  in  rats. 
Environ. Health Perspect. 2001, 109, 547−551. Int. J. Mol. Sci. 2011, 12                       
 
 
6276
22.  Begley, D.J. The blood-brain barrier: Principles for targeting peptides and drugs to the central 
nervous system. J. Pharm. Pharmacol. 1996, 48, 136−146. 
23.  Sharma,  H.S.;  Sharma,  A.  Nanoparticles  aggravate  heat  stress  induced  cognitive  deficits,  
blood-brain barrier disruption, edema formation and brain pathology. Prog. Brain Res. 2007, 162, 
245–273. 
24.  Sharma, H.S.; Sharma, A. Conference scene: Nanoneuroprotection and nanoneurotoxicity: Recent 
progress and future perspectives. Nanomedicine 2010, 5, 533–537. 
25.  De  Lorenzo,  A.J.D.  The  olfactory  neuron  and  the  blood-brain  barrier.  In  Taste  and  Smell  in 
Vertebrates;  Wolstenholme,  G.E.W.,  Knight,  J.,  Eds.;  J.  &A.  Churchill:  London,  UK,  1970;  
pp. 151–176. 
26.  Tjälve, H.; Henriksson, J.; Tallkvist, J.; Larsson, B.S.; Lindquist, N.G. Uptake of manganese and 
cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. 
Pharmacol. Toxicol. 1996, 79, 347–356. 
27.  Tallkvist, J.; Henriksson, J.; d’Argy, R.; Tjälve, H. Transport and subcellular distribution of nickel 
in the olfactory system of pikes and rats. Toxicol. Sci. 1998, 43, 196–203. 
28.  Tjalve, H.; Henriksson, J. Uptake of metals in the brain via olfactory pathways. Neurotoxicology 
1999, 20, 181–196. 
29.  Henriksson, J.; Tjälve, H. Manganese taken up into the CNS via the olfactory pathway in rats 
affects astrocytes. Toxicol. Sci. 2000, 55, 392–398. 
30.  Persson, E.; Henriksson, J.; Tjälve, H. Uptake of cobalt from the nasal mucosa into the brain via 
olfactory pathways in rats. Toxicol. Lett. 2003, 145, 19–27. 
31.  Elder, A.; Gelein, R.; Silva, V.; Feikert, T.; Opanashuk, L.; Carter, J.; Potter, R.; Maynard, A.;  
Ito,  Y.;  Finkelstein,  J.;  Oberdorster,  G.  Translocation  of  inhaled  ultrafine  manganese  oxide 
particles to the central nervous system. Environ. Health Perspect. 2006, 114, 1172–1178. 
32.  Win-Shwe, T.T.; Yamamoto, S.; Ahmed, S.; Kakeyama, M.; Kobayashi, T.; Fujimaki, H. Brain 
cytokine  and  chemokine  mRNA  expression  in  mice  induced  by  intranasal  instillation  with 
ultrafine carbon black. Toxicol. Lett. 2006, 163, 153−160. 
33.  Zhang, Q.; Kusaka, Y.; Sato, K.; Nakakuki, K.; Kohyama, N.; Donaldson, K. Differences in the 
extent of inflammation caused by intratracheal exposure to three ultrafine metals: Role of free 
radicals. J. Toxicol. Environ. Health A. 1998, 53, 423−438. 
34.  Dellinger, B.; Pryor, W.A.; Cueto, R.; Squadrito, G.L.; Hegde, V.; Deutsch, W.A. Role of free 
radicals in the toxicity of airborne fine particulate matter. Chem. Res. Toxicol. 2001, 14, 1371–1377. 
35.  Li, N.; Sioutas, C.; Cho, A.; Schmitz, D.; Misra, C.; Sempf, J.; Wang, M.; Oberley, T.; Froines, J.; 
Nel,  A.  Ultrafine  particulate  pollutants  induce  oxidative  stress  and  mitochondrial  damage. 
Environ. Health Perspect. 2003, 111, 455–460. 
36.  Veronesi,  B.;  Makwana,  O.;  Pooler,  M.;  Chen,  L.C.  Effects  of  subchronic  exposures  to 
concentrated ambient particles. VII.  Degeneration of dopaminergic  neurons  in  Apo E
−/− mice. 
Inhal. Toxicol. 2005, 17, 235−241. 
37.  Nel, A.; Xia, T.; Mädler, L.; Li, N. Toxic potential of materials at the nanolevel. Science 2006, 
311, 622–627. 
38.  Donaldson, K.; Stone, V. Current hypotheses on the mechanisms of toxicity of ultrafine particles. 
Ann. Ist. Super Sanita. 2003, 39, 405–410. Int. J. Mol. Sci. 2011, 12                       
 
 
6277
39.  Brown, D.M.; Stone, V.; Findlay, P.; MacNee, W.; Donaldson, K. Increased inflammation and 
intracellular calcium caused by ultrafine carbon black is independent of transition metals or other 
soluble components. Occup. Environ. Med. 2000, 57, 685−691. 
40.  Brown,  D.M.;  Wilson,  M.R.;  MacNee,  W.;  Stone,  V.;  Donaldson,  K.  Size-dependent 
proinflammatory effects of ultrafine polystyrene particles: A role for surface area and oxidative 
stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol. 2001, 175, 191−199. 
41.  Derfus, A.M.; Chan, W.C.W.; Bhatia, S.N. Probing the cytotoxicity of semiconductor quantum 
dots. Nano Lett. 2004, 4, 11–18. 
42.  Joo, S.H.; Feitz, A.J.; Waite, T.D. Oxidative degradation of the carbothioate herbicide, molinate, 
using nanoscale zero-valent iron. Environ. Sci. Technol. 2004, 38, 2242−2247. 
43.  Oberdörster, E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain 
of juvenile largemouth bass. Environ. Health Perspect. 2004, 112, 1058−1062. 
44.  Sayes, C.; Fortner, J.; Guo, W.; Lyon, D.; Boyd, A.M.; Ausman, K.D.; Tao, Y.J.; Sitharaman, B.; 
Wilson, L.J.; Hughes, J.B.; West, J.L.; Colvin, V.L. The differential cytotoxicity of water-soluable 
fullerenes. Nano Lett. 2004, 4, 1881–1887. 
45.  Shvedova,  A.A.;  Castranova,  V.;  Kisin,  E.R.;  Schwegler-Berry,  D.;  Murray,  A.R.;  
Gandelsman, V.Z.; Maynard, A.; Baron, P. Exposure to carbon nanotube material: Assessment of 
nanotube cytotoxicity using human keratinocyte cells. J. Toxicol. Environ. Health A. 2003, 66, 
1909–1926. 
46.  Shvedova, A.A.; Kisin, E.R.; Murray, A.R.; Schwegler-Berry, D.; Gandelsnan, V.Z.; Baron, P.; 
Maynard,  A.;  Gunther,  M.R.;  Castranova,  V.  Exposue  of  human  bronchial  cells  to  carbon 
nanotubes caused oxidative stress and cytotoxicity. In Proceedings of the Society for Free Radical 
Research Meeting, Ioannina, Greece, 26–29 June 2003; Taylor & Francis Group: Philadelphia, 
PA, USA, 2003; pp. 91–103. 
47.  Wilson, M.R.; Lightbody, J.H.; Donaldson, K.; Sales, J.; Stone, V. Interactions between ultrafine 
particles and transition metals in vivo and in vitro. Toxicol. Appl. Pharmacol. 2002, 184, 172−179. 
48.  Yamakoshi,  Y.;  Umezawa,  N.;  Ryu,  A.;  Arakane,  K.;  Miyata,  N.;  Goda,  Y.;  Masumizu,  T.; 
Nagano,  T.  Active  oxygen  species  generated  from  photoexcited  fullerene  (C60)  as  potential 
medicines: O
2−* versus 
1O2. J. Am. Chem. Soc. 2003, 125, 1283−1289. 
49.  Rahman,  M.F.;  Wang,  J.;  Patterson,  T.A.;  Saini,  U.T.;  Robinson,  B.L.;  Newport,  G.D.;  
Murdock, R.C.; Schlager, J.J.; Hussain, S.M.; Ali, S.F. Expression of genes related to oxidative 
stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett. 2009, 187, 15–21. 
50.  Shimizu, M.; Tainaka, H.; Oba, T.; Mizuo, K.; Umezawa, M.; Takeda, K. Maternal exposure to 
nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain 
development in the mouse. Part. Fibre Toxicol. 2009, 6, 1–8. 
51.  Campbell,  A.;  Oldham,  M.;  Becaria,  A.;  Bondy,  S.C.;  Meacher,  D.;  Sioutas,  C.;  Misra,  C.; 
Mendez,  L.B.;  Kleinman,  M.  Particulate  matter  in  pollutant  air  may  increase  biomarkers  of 
inflammation in mouse brain. Neurotoxicology 2005, 26, 133–140. 
52.  Win-Shwe,  T.T.;  Mitsushima,  D.;  Yamamoto,  S.;  Fujitani,  Y.;  Funabashi,  T.;  Hirano,  S.;  
Fujimaki,  H.  Extracellular  glutamate  level  and  NMDA  receptor  subunit  expression  in  mouse 
olfactory  bulb  following  nanoparticle-rich  diesel  exhaust  exposure.  Inhal.  Toxicol.  2009,  21, 
828−836. Int. J. Mol. Sci. 2011, 12                       
 
 
6278
53.  Borm, P.J.; Müller-Schulte, D. Nanoparticles in drug delivery and environmental exposure: Same 
size, same risks? Nanomedicine 2006, 1, 235−249. 
54.  Win-Shwe, T.T.; Yamamoto, S.; Fujitani, Y.; Hirano, S.; Fujimaki, H. Spatial learning and memory 
function-related gene expression in the hippocampus of mouse exposed to nanoparticle-rich diesel 
exhaust. Neurotoxicology 2008, 29, 940−947. 
55.  Win-Shwe, T.T.; Yamamoto, S.; Fujitani, Y.; Hirano, S.; Fujimaki, H. Nanoparticle-rich diesel 
exhaust affects hippocampal-dependent spatial learning and NMDA receptor subunit expression 
in female mice. Nanotoxicology 2011, DOI: 10.3109/17435390.2011.590904. 
56.  Tsukue, N.; Watanabe, M.; Kumamoto, T.; Takano, H.; Takeda, K. Perinatal exposure to diesel 
exhaust affects gene expression in mouse cerebrum. Arch. Toxicol. 2009, 83, 985–1000. 
57.  Suzuki, T.; Oshio, S.; Iwata, M.; Saburi, H.; Odagiri, T.; Udagawa, T.; Sugawara, I.; Umezawa, M.; 
Takeda,  K.  In  utero  exposure  to  a  low  concentration  of  diesel  exhaust  affects  spontaneous 
locomotor activity and monoaminergic system in male mice. Part. Fibre Toxicol. 2010, 7, 1–8. 
58.  Win-Shwe, T.T.; Mitsushima, D.; Yamamoto, S.; Fukushima, A.; Funabashi, T.; Kobayashi, T.; 
Fujimaki,  H.  Changes  in  neurotransmitter  levels  and  proinflammatory  cytokine  mRNA 
expressions  in  the  mice  olfactory  bulb  following  nanoparticle  exposure.  Toxicol.  Appl. 
Pharmacol. 2008, 226, 192−198. 
59.  Kleinman, M.T.; Araujo, J.A.; Nel, A.; Sioutas, C.; Campbell, A.; Cong, P.Q.; Li, H.; Bondy, S.C. 
Inhaled ultrafine particulate matter affects CNS inflammatory processes and may act via MAP 
kinase signaling pathways. Toxicol. Lett. 2008, 178, 127–130. 
60.  Zhang, Q.L.; Li, M.Q.; Ji, J.W.; Gao, F.P.; Bai, R.; Chen, C.Y.; Wang, Z.W.; Zhang, C.; Niu, Q. 
In vivo toxicity of nano-alumina on mice neurobehavioral profiles and the potential mechanisms. 
Int. J. Immunopathol. Pharmacol. 2011, 24, 23S–29S. 
61.  Takahashi,  Y.;  Mizuo,  K.;  Shinkai,  Y.;  Oshio,  S.;  Takeda,  K.  Prenatal  exposure  to  titanium 
dioxide nanoparticles increases dopamine levels in the prefrontal cortex and neostriatum of mice. 
J. Toxicol. Sci. 2010, 35, 749–756. 
62.  Takeda,  K.;  Suzuki,  K.;  Ishihara,  A.;  Kubo-Irie,  M.;  Fujimoto,  R.;  Tabata,  M.;  Oshio,  S.;  
Nihei, Y.; Ihara, T.; Sugamata, M. Nanoparticles transferred from pregnant mice to their offspring 
can damage the genital and cranial nerve systems. J. Health Sci. 2009, 55, 95–102. 
63.  Takeda,  K.;  Shinkai,  Y.;  Suzuki,  K.;  Yanagita,  S.;  Umezawa,  M.;  Yokota,  S.;  Tainaka,  H.;  
Oshio, S.; Ihara, T.; Sugamata, M. Health effects of nanomaterials on next generation. Yakugaku 
Zasshi 2011, 131, 229–236. 
64.  Hartz, A.M.; Bauer, B.; Block, M.L.; Hong, J.S.; Miller, D.S. Diesel exhaust particles induce 
oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood brain 
barrier. FASEB J. 2008, 22, 2723−2733. 
65.  Levesque, S.; Taetzsch, T.; Lull, M.E.; Kodavanti, U.; Stadler, K.; Wagner, A.; Johnson, J.A.; 
Duke, L.; Kodavanti, P.; Surace, M.J.; Block, M.L. Diesel exhaust activates and primes microglia: 
Air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity. Environ. Health 
Perspect. 2011, 119, 1149−1155. 
66.  Hussain,  S.M.;  Javorina,  A.K.;  Schrand,  A.M.;  Duhart,  H.M.;  Ali,  S.F.;  Schlager,  J.J.  The 
interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol. 
Sci. 2006, 92, 456−463. Int. J. Mol. Sci. 2011, 12                       
 
 
6279
67.  Pisanic, T.R., II.; Blackwell, J.D.; Shubayev, V.I.; Fiñones, R.R.; Jin, S. Nanotoxicity of iron 
oxide nanoparticle internalization in growing neurons. Biomaterials 2007, 28, 2572–2581. 
68.  Wang,  J.;  Rahman,  M.F.;  Duhart,  H.M.;  Newport,  G.D.;  Patterson,  T.A.;  Murdock,  R.C.;  
Hussain, S.M.; Schlager, J.J.; Ali, S.F. Expression changes of dopaminergic system-related genes 
in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 2009, 30, 
926−933. 
69.  Wu, J.; Wang, C.; Sun, J.; Xue, Y. Neurotoxicity of silica nanoparticles: Brain localization and 
dopaminergic neurons damage pathways. ACS Nano. 2011, 5, 4476−4489. 
70.  Wu, X.F.; Block, M.L.; Zhang, W.; Qin, L.; Wilson, B.; Zhang, W.Q.; Veronesi, B.; Hong, J.S. 
The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid. Redox Signal. 
2005, 7, 654−661. 
71.  Long,  T.C.;  Tajuba,  J.;  Sama,  P.;  Saleh,  N.;  Swartz,  C.;  Parker,  J.;  Hester,  S.;  Lowry,  G.V.; 
Veronesi, B. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and 
damages neurons in vitro. Environ. Health Perspect. 2007, 115, 1631–1637. 
72.  Deng, X.; Luan, Q.; Chen, W.; Wang, Y.; Wu, M.; Zhang, H.; Jiao, Z. Nanosized zinc oxide 
particles induce neural stem cell apoptosis. Nanotechnology 2009, 20, 115101. 
73.  Calderón-Garcidueñas, L.; Reed, W.; Maronpot, R.R.; Henríquez-Roldán, C.; Delgado-Chavez, R.; 
Calderón-Garcidueñas,  A.;  Dragustinovis,  I.;  Franco-Lira,  M.;  Aragón-Flores,  M.;  Solt,  A.C.; 
Altenburg,  M.;  Torres-Jardón,  R.;  Swenberg,  J.A.  Brain  inflammation  and  Alzheimer’s-like 
pathology in individuals exposed to severe air pollution. Toxicol. Pathol. 2004, 32, 650–658. 
74.  United States Environmental Protection Agency (US EPA). Integrated Science Assessment for 
Particulate Matter. EPA/600/R-08/139F. EPA: Washington, DC, USA, December 2009.  
75.  Hoek, G.; Boogaard, H.; Knol, A.; de Hartog, J.; Slottje, P.; Ayres, J.G.; Borm, P.; Brunekreef, B.; 
Donaldson, K.; Forastiere, F.; Holgate, S.; Kreyling, W.G.; Nemery, B.; Pekkanen, J.; Stone, V.; 
Wichmann, H.E.; van der Sluijs, J. Concentration response functions for ultrafine particles and 
all-cause  mortality  and  hospital  admissions:  Results  of  a  European  expert  panel  elicitation. 
Environ. Sci. Technol. 2010, 44, 476−482. 
76.  Hesterberg,  T.W.;  Long,  C.M.;  Lapin,  C.A.;  Hamade,  A.K.;  Valberg,  P.A.  Diesel  exhaust 
particulate (DEP) and nanoparticle exposures: What do DEP human clinical studies tell us about 
potential human health hazards of nanoparticles? Inhal. Toxicol. 2010, 22, 679−694. 
77.  Kittelson,  D.B.;  Watts,  W.F.;  Johnson,  J.P.;  Remerowki,  M.L.;  Ische,  E.E.;  Oberdörster,  G.; 
Gelein,  R.M.;  Elder,  A.;  Hopke,  P.K.;  Kim,  E.;  Zhao,  W.;  Zhou,  L.;  Jeong,  C.H.  On-road 
exposure  to  highway  aerosols.  1.  Aerosol  and  gas  measurements.  Inhal.  Toxicol.  2004,  16S, 
31−39. 
78.  Kittelson,  D.B.  On-Road  Particles-Characteristics  and  Measurement.  In  Proceedings  of  the 
International  Workshop  on  Vehicle-related  Nanoparticles  and  Environmental  Health,  Seoul, 
Korea, 2 February 2007; pp. 47−71. 
79.  Crüts, B.; van Etten, L.; Törnqvist, H.; Blomberg, A.; Sandström, T.; Mills, N.L.; Borm, P.J. 
Exposure to diesel exhaust induces changes in EEG in human volunteers. Part. Fibre Toxicol. 
2008, 5, 1−6. 
 Int. J. Mol. Sci. 2011, 12                       
 
 
6280
80.  Frampton, M.W.; Utell, M.J.; Zareba, W.; Oberdörster, G.; Cox, C.; Huang, L.S.; Morrow, P.E.; 
Lee, F.E.; Chalupa, D.; Frasier, L.M.; Speers, D.M.; Stewart, J. Effects of exposure to ultrafine 
carbon particles in healthy subjects and subjects with asthma. Res. Rep. Health Eff. Inst. 2004, 
126, 1–47. 
81.  Beckett, W.S.; Chalupa, D.F.; Pauly-Brown, A.; Speers, D.M.; Stewart, J.C.; Frampton, M.W.; 
Utell, M.J.; Huang, L.S.; Cox, C.; Zareba, W.; Oberdörster, G. Comparing inhaled ultrafine versus 
fine zinc oxide particles in healthy adults: A human inhalation study. Am. J. Respir. Crit. Care 
Med. 2005, 171, 1129−1135. 
82.  Song,  Y.;  Li,  X.;  Du,  X. Exposure to  nanoparticles  is  related  to  pleural  effusion,  pulmonary 
fibrosis and granuloma. Eur. Respir. J. 2009, 34, 559−567. 
83.  Gwinn,  M.R.;  Vallyathan,  V.  Nanoparticles:  Health  effects-pros  and  cons.  Environ.  Health 
Perspect. 2006, 114, 1818−1825. 
©  2011  by  the  authors;  licensee  MDPI,  Basel,  Switzerland.  This  article  is  an  open  access  article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 